(FPE) Fuchs Petrolub SE - Ratings and Ratios
Engine Oil, Industrial Grease, Metal Fluid, Farm Lube, Wind Turbine Oil
FPE EPS (Earnings per Share)
FPE Revenue
Description: FPE Fuchs Petrolub SE
Fuchs SE is a global lubricant and functional fluid developer, manufacturer, and distributor with a diverse product portfolio catering to various industries, including automotive, industrial, aerospace, and more. The companys extensive range of products includes automotive and industrial lubricants, lubricating greases, metal processing lubricants, and special application lubricants.
From a financial perspective, Fuchs SE has a market capitalization of approximately €5.53 billion, indicating a significant presence in the specialty chemicals sector. With a price-to-earnings ratio of 14.02 and a forward P/E of 15.50, the companys valuation appears reasonable. Additionally, the return on equity (RoE) stands at 16.30%, suggesting a decent level of profitability.
To further analyze the companys performance, we can examine key performance indicators (KPIs) such as revenue growth, gross margin, and operating margin. A review of the companys financial statements reveals that Fuchs SE has consistently demonstrated stable revenue growth, with a gross margin of around 30-35%. The operating margin is also respectable, indicating effective cost management. Furthermore, the companys dividend yield and payout ratio can be evaluated to assess its attractiveness to income-seeking investors.
From a growth perspective, Fuchs SEs presence in various regions, including Europe, the Americas, and Asia Pacific, provides a diversified revenue stream. The companys ability to adapt to changing market trends, such as the increasing demand for biodegradable lubricants and the growing need for specialized lubricants in emerging industries, will be crucial in driving future growth. An analysis of the companys research and development (R&D) expenses and innovation pipeline can provide insights into its ability to stay competitive in the market.
FPE Stock Overview
| Market Cap in USD | 5,568m |
| Sub-Industry | Specialty Chemicals |
| IPO / Inception |
FPE Stock Ratings
| Growth Rating | 31.4% |
| Fundamental | 76.0% |
| Dividend Rating | 59.4% |
| Return 12m vs S&P 500 | -9.77% |
| Analyst Rating | - |
FPE Dividends
| Dividend Yield 12m | 3.62% |
| Yield on Cost 5y | 4.57% |
| Annual Growth 5y | 2.76% |
| Payout Consistency | 92.6% |
| Payout Ratio | 51.8% |
FPE Growth Ratios
| Growth Correlation 3m | -76.1% |
| Growth Correlation 12m | 39.1% |
| Growth Correlation 5y | 51.7% |
| CAGR 5y | 4.54% |
| CAGR/Max DD 5y | 0.11 |
| Sharpe Ratio 12m | -0.16 |
| Alpha | -3.82 |
| Beta | 0.484 |
| Volatility | 20.88% |
| Current Volume | 34.9k |
| Average Volume 20d | 21k |
| Stop Loss | 30.8 (-3.1%) |
| Signal | -1.15 |
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income (291.0m TTM) > 0 and > 6% of Revenue (6% = 213.9m TTM) |
| FCFTA 0.13 (>2.0%) and ΔFCFTA -1.32pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 18.57% (prev 19.52%; Δ -0.95pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.16 (>3.0%) and CFO 406.0m > Net Income 291.0m (YES >=105%, WARN >=100%) |
| Net Debt (59.0m) to EBITDA (533.0m) ratio: 0.11 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.00 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (131.0m) change vs 12m ago -0.23% (target <= -2.0% for YES) |
| Gross Margin 34.61% (prev 33.82%; Δ 0.79pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 140.1% (prev 139.9%; Δ 0.17pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 61.57 (EBITDA TTM 533.0m / Interest Expense TTM 7.00m) >= 6 (WARN >= 3) |
Altman Z'' 3.36
| (A) 0.25 = (Total Current Assets 1.32b - Total Current Liabilities 660.0m) / Total Assets 2.60b |
| (B) 0.06 = Retained Earnings (Balance) 144.0m / Total Assets 2.60b |
| (C) 0.17 = EBIT TTM 431.0m / Avg Total Assets 2.55b |
| (D) 0.35 = Book Value of Equity 275.0m / Total Liabilities 785.0m |
| Total Rating: 3.36 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 75.96
| 1. Piotroski 7.50pt = 2.50 |
| 2. FCF Yield 7.31% = 3.66 |
| 3. FCF Margin 9.85% = 2.46 |
| 4. Debt/Equity 0.08 = 2.50 |
| 5. Debt/Ebitda 0.29 = 2.44 |
| 6. ROIC - WACC 8.29% = 10.36 |
| 7. RoE 15.60% = 1.30 |
| 8. Rev. Trend -7.05% = -0.35 |
| 9. Rev. CAGR -0.89% = -0.15 |
| 10. EPS Trend 47.19% = 1.18 |
| 11. EPS CAGR 0.72% = 0.07 |
What is the price of FPE shares?
Over the past week, the price has changed by -2.45%, over one month by +0.63%, over three months by -5.36% and over the past year by +5.54%.
Is Fuchs Petrolub SE a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of FPE is around 29.11 EUR . This means that FPE is currently overvalued and has a potential downside of -8.46%.
Is FPE a buy, sell or hold?
What are the forecasts/targets for the FPE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 48 | 50.9% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 32.2 | 1.2% |
FPE Fundamental Data Overview
Market Cap EUR = 4.78b (4.78b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 134.0m EUR (Cash And Short Term Investments, last quarter)
P/E Trailing = 14.276
P/E Forward = 15.5039
P/S = 1.3408
P/B = 2.2255
Beta = 0.745
Revenue TTM = 3.56b EUR
EBIT TTM = 431.0m EUR
EBITDA TTM = 533.0m EUR
Long Term Debt = 8.00m EUR (from longTermDebt, last quarter)
Short Term Debt = 146.0m EUR (from shortTermDebt, last quarter)
Debt = 154.0m EUR (Calculated: Short Term 146.0m + Long Term 8.00m)
Net Debt = 59.0m EUR (from netDebt column, last quarter)
Enterprise Value = 4.80b EUR (4.78b + Debt 154.0m - CCE 134.0m)
Interest Coverage Ratio = 61.57 (Ebit TTM 431.0m / Interest Expense TTM 7.00m)
FCF Yield = 7.31% (FCF TTM 351.0m / Enterprise Value 4.80b)
FCF Margin = 9.85% (FCF TTM 351.0m / Revenue TTM 3.56b)
Net Margin = 8.16% (Net Income TTM 291.0m / Revenue TTM 3.56b)
Gross Margin = 34.61% ((Revenue TTM 3.56b - Cost of Revenue TTM 2.33b) / Revenue TTM)
Tobins Q-Ratio = 17.45 (Enterprise Value 4.80b / Book Value Of Equity 275.0m)
Interest Expense / Debt = 1.30% (Interest Expense 2.00m / Debt 154.0m)
Taxrate = 29.44% (from yearly Income Tax Expense: 126.0m / 428.0m)
NOPAT = 304.1m (EBIT 431.0m * (1 - 29.44%))
Current Ratio = 2.00 (Total Current Assets 1.32b / Total Current Liabilities 660.0m)
Debt / Equity = 0.08 (Debt 154.0m / last Quarter total Stockholder Equity 1.81b)
Debt / EBITDA = 0.29 (Net Debt 59.0m / EBITDA 533.0m)
Debt / FCF = 0.44 (Debt 154.0m / FCF TTM 351.0m)
Total Stockholder Equity = 1.87b (last 4 quarters mean)
RoA = 11.19% (Net Income 291.0m, Total Assets 2.60b )
RoE = 15.60% (Net Income TTM 291.0m / Total Stockholder Equity 1.87b)
RoCE = 23.00% (Ebit 431.0m / (Equity 1.87b + L.T.Debt 8.00m))
RoIC = 15.87% (NOPAT 304.1m / Invested Capital 1.92b)
WACC = 7.59% (E(4.78b)/V(4.93b) * Re(7.80%)) + (D(154.0m)/V(4.93b) * Rd(1.30%) * (1-Tc(0.29)))
Shares Correlation 5-Years: -97.50 | Cagr: -1.57%
Discount Rate = 7.80% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 80.80% ; FCFE base≈358.2m ; Y1≈422.3m ; Y5≈649.1m
Fair Price DCF = 169.9 (DCF Value 11.13b / Shares Outstanding 65.5m; 5y FCF grow 19.07% → 3.0% )
Revenue Correlation: -7.05 | Revenue CAGR: -0.89%
Rev Growth-of-Growth: 4.04
EPS Correlation: 47.19 | EPS CAGR: 0.72%
EPS Growth-of-Growth: -11.60